Poland· PL-100410232
Slinda
A drospirenone product containing drospirenonum, registered in Poland by Exeltis Poland Sp. z o.o.. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Drospirenone is registered in 13 of 19 countries.
Countries holding a registration under ATC G03AC10 (drospirenone), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Drospirenone · ATC G03AC10
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Drospirenonum
- Manufacturer
- Exeltis Poland Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- G03AC10
- ATC class
- Drospirenone
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991420734
- gtin05909991420741
- gtin05909991420758
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
172 interactions on record for drospirenone.
Graded by severity as the source publishes them — 27 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Drospirenone · interactions on record
172 records
- 27 severe
- 143 moderate
- 2 minor
Most severe, free to view
- Tranexamic acidB02AA02severe
- GriseofulvinD01AA08severe
- GriseofulvinD01BA01severe
- KetoconazoleH02CA03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Drospirenone in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandSlinda 4.0 mg, FilmtablettenExeltis Suisse SA
- CzechiaZLYNDAExeltis Czech s.r.o., Praha
- SpainSLINDA 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULAExeltis Healthcare S.L.
- FinlandSlindaExeltis Healthcare S.L.
- FranceSLINDA 4 mg, comprimé pelliculéEXELTIS SANTE
- IrelandSlyndy 4 mg film-coated tabletsExeltis Healthcare S.L.
- IcelandSlindaExeltis Healthcare S.L.*
- NetherlandsSlinda 4 mg filmomhulde tablettenExeltis Healthcare S.L
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9d30e33a-42ca-4782-949d-6075c65bbd00 GET /v1/drugs/9d30e33a-42ca-4782-949d-6075c65bbd00?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "4 mg",
"packaging": "05909991420734 ¦ Rp ¦ 134940\n28 tabl.\n05909991420741 ¦ Rp ¦ 134941\n84 tabl.\n05909991420758 ¦ Rp ¦ 134942\n168 tabl.",
"substance": "Drospirenonum 4 mg",
"common_name": "Drospirenonum",
"pl_product_id": "100410232",
"pozwolenie_nr": "25666",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about drospirenone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.